Treatment of pulmonary vein stenosis with expanded polytetrafluoroethylene covered stents.
Atrium expanded polytetrafluoroethylene covered stents were implanted in the stenotic pulmonary veins (n = 5) of three patients. Use of this device was feasible in infants and the procedure was well-tolerated without major complications. The majority (4/5) of covered stents remained patent for at least 3 months after implantation. Stents remain patent in the two surviving patients 6 months after deployment.
Gordon
Brent M
BM
Division of Pediatric Cardiology, Rady Children's Hospital-San Diego, University of California, San Diego, California 92123, USA. mcnairygordo@yahoo.com
Moore
John W
JW
D000800:Angioplasty, Balloon / Q000295:instrumentation*; D002648:Child; D002675:Child, Preschool; D003251:Constriction, Pathologic; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D010690:Phlebography; D011138:Polytetrafluoroethylene; D011474:Prosthesis Design; D011668:Pulmonary Veno-Occlusive Disease / Q000000981:diagnostic imaging / Q000503:physiopathology / Q000628:therapy*; D015607:Stents; D016896:Treatment Outcome; D014654:Vascular Patency
D011138:Polytetrafluoroethylene